On May 10, 2021, the FDA authorized the Pfizer mRNA Covid vaccine for use in children 12 years of age and older in the USA. Following suit, the EMA has suggested that youngsters in the EU who are 12 years old and older receive the Pfizer vaccine.
Because of this, there is no reason to have any doubt that the MHRA will follow the FDA’s and EMA’s lead and likewise give the Pfizer vaccine emergency use authorization for use in children 12 years of age and older.
But did you know that according to Pfizer’s clinical trials on kids between the ages of 12 and 15, 86% of those who received at least one dose of the vaccine experienced mild to severe side effects?
On May 10, 2021, the FDA authorized the Pfizer mRNA Covid vaccine for use in children 12 years of age and older in the USA. Following suit, the EMA has suggested that youngsters in the EU who are 12 years old and older receive the Pfizer vaccine.
Because of this, there is no reason to have any doubt that the MHRA will follow the FDA’s and EMA’s lead and likewise give the Pfizer vaccine emergency use authorization for use in children 12 years of age and older.
But did you know that according to Pfizer’s clinical trials on kids between the ages of 12 and 15, 86% of those who received at least one dose of the vaccine experienced mild to severe side effects?
The information is publicly available and contained within an FDA fact sheet which can be viewed here (see page 25, table 5 on-wards).
Two tables in that data sheet provide worrisome information about the side effects and damage suffered by 12- to 15-year-old kids who had at least one dosage of the Pfizer mRNA “vaccine” (gene therapy).
Only 1,097 of the 1,127 children who received the first dosage of the mRNA vaccine also received the second dose, according to the tables. This fact alone begs the issue of why 30 kids did not receive a second dosage of the Pfizer vaccine, and we have our doubts about the answer’s aesthetics.
A startling 86% of the 1,127 kids who received the vaccine for the first time had a negative reaction. A startling 78.9% of the 1,097 kids who received a second dosage of the vaccine had an unfavorable reaction.
20.3% of the 1,127 children who received the Pfizer vaccine’s first dose and 39.3% of the 1,097 children who received it twice both reported fever, according to Table 6 in the FDA fact sheet.
Sixty-six percent of the kids who received the second dose also felt fatigued, compared to another 60.1% of the kids who received the first dose.
A headache was also experienced by an additional 55.3% of the kids who received the first dose and 64.5% of the kids who got the second dose.
Chills were also experienced by 27.6% of the children who received the first dose, and by 41.5% of the children who received the second dose. Vomiting occurred in 2.8% of the children who received the first dose and 2.6% of the children who received the second dose.
Diarrhea is the FDA’s final specified adverse reaction. 8.0% of the 1,127 kids who got the first dosage experienced diarrhea. 5.9% of the 1,097 kids who received a second dosage of the medication developed diarrhea.
It’s alarming to see that the trial was permitted to continue and that the same kids received a second dosage of the vaccine despite the fact that 86% of them had reported an adverse reaction after the first dose.
The FDA report also mentions that 0.04% experienced an extremely serious adverse event, but it doesn’t elaborate on the specific types of reactions that took place. 0.04% might seem insignificant, but let’s put it in context. There are roughly 4 million kids in the UK between the ages of 12 and 15 years old. According to the study, 1,600 children might experience a very serious adverse reaction after receiving just one dosage of the Pfizer mRNA vaccine which could also include death.
We should expect to see that number rise to about 5,200 if this is subsequently extended to children under the age of 12 and a similar rate of extremely serious adverse reactions happens.
However, it is important to remember that the study found that 86% of recipients experienced a negative reaction. This indicates that 3.4 million children aged 12 to 15 who receive just one dose of the Pfizer vaccine are likely to experience a negative reaction.
We are perplexed by how medical regulators came to the conclusion that the advantages of these experimental vaccines exceed the risks when we contrast this rate with the actual risk of children even mildly exhibiting the purported Covid-19 sickness.
And these are experimental vaccines, the FDA document even tells the public this in which it states the following –
‘The Pfizer-BioNTech COVID-19 Vaccine is an unapproved vaccine that may prevent COVID-19. There is no FDA-approved vaccine to prevent COVID-19. The FDA has authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine to prevent COVID-19 in individuals 12 years of age and older under an Emergency Use Authorization (EUA).‘
Additionally, the FDA affirms in its fact sheet that all Covid vaccines, including the Pfizer vaccine, are still undergoing clinical studies.
There could be serious and unexpected negative effects.
This link (https://www.fda.gov/media/144413/download) in your article goes to an FDA page that says it doesn’t exist or is out of date? What did the page look like before they made it ‘out of date’?
Thanks,
Buddy
Clearly you live in a warped reality if you drew the above conclusions from the data provided. Instead of stupidly highlighting the 3% who didn’t get a 2nd vaccine, maybe focus on the overwhelming 97% of parents who were happy to give their child a 2nd dose. Clearly the ‘adverse’ effects you are trying to scaremonger people about were nothing for those 97% to worry about. It’s also funny how you made zero reference to all the ‘adverse’ reactions from a placebo. With such a high number of ‘fatigue’ side effects reported by kids from a basic placebo, the vaccine responses relating to fatigue (the highest side effect) is clearly unreliable. The only news story here is about parents trying to do the right thing and protect their kids from Covid. Just more fake news from a dimwit author trying to push a dangerous agenda.
SACRAMENTO, CA — Former Los Angeles Mayor and current California gubernatorial candidate Antonio Villaraigosa has publicly alleged that Kamala Harris and Xavier Becerra were involved in concealing former President Joe Biden’s mental and physical decline during his time in office.
Villaraigosa, a Democrat, made the claim amid a heated California gubernatorial race. Becerra, the former Secretary of Health and Human Services, is also a candidate, while speculation continues over a potential Harris bid. The race comes as current Governor Gavin Newsom reaches the end of his second and final term, per California’s two-term limit.
In a statement referencing recent reporting and excerpts from the book Original Sin, Villaraigosa stated:
“What I’ve seen in news coverage and excerpts from the new book ‘Original Sin’ is deeply troubling. At the highest levels of our government, those in power were intentionally complicit or told outright lies in a systematic cover up to keep Joe Biden’s mental decline from the public.”
Both Harris and Becerra previously served as California Attorney General. Villaraigosa emphasized their past leadership roles, stating:
“Now, we have come to learn this cover up includes two prominent California politicians who served as California Attorney General – one who is running for Governor and another who is thinking about running for Governor.”
He added:
“Those who were complicit in the cover up should take responsibility for the part they played in this debacle, hold themselves accountable, and apologize to the American people. I call on Kamala Harris and Xavier Becerra to do just that – and make themselves available to voters and the free press because there’s a lot of questions that need to be answered.”
Becerra responded in a statement, saying:
“It’s clear the President was getting older, but he made the mission clear: run the largest health agency in the world, expand care to millions more Americans than ever before, negotiate down the cost of prescription drugs, and pull us out of a world-wide pandemic. And we delivered.”
Kamala Harris has not issued a public response. Fox News Digital reported that it reached out to the offices of Harris and the Bidens but had not received a reply at the time of publication.
The allegations come as discussions about Biden’s cognitive and physical health continue. Earlier this month, during an appearance on The View, Biden dismissed claims of cognitive decline during his presidency.
In related developments, Biden’s personal office recently confirmed that he had been diagnosed with prostate cancer characterized by a high Gleason score and metastasis to the bone.
Villaraigosa’s comments are the latest in a growing list of concerns raised within the Democratic Party about leadership transparency and accountability in the final years of the Biden administration.
A newly released interim report from Senator Ron Johnson’s office claims top U.S. health officials in the Biden administration withheld critical information in early 2021 about potential heart-related side effects associated with mRNA COVID-19 vaccines. The 54-page report alleges that despite receiving multiple warnings about the risks—particularly cases of myocarditis and related conditions in young people—federal agencies delayed issuing formal alerts for several months.
According to the report, health officials at the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) were informed as early as February 2021 about international concerns, including an attempt by Israel’s Ministry of Health to raise alarm over roughly 40 myocarditis cases tied to the Pfizer vaccine. At that time, Israel’s vaccination campaign was further along than the U.S.’s, offering an early view of potential adverse effects.
In response to Israel’s outreach, FDA officials acknowledged limitations in existing data and asked for further information. However, despite growing domestic reports of heart inflammation—more than 158 cases by April—the agencies did not formally update the public until late June. The vaccine was nonetheless approved for adolescents in May.
By late May, internal deliberations began over whether to issue a Health Alert Network (HAN) message, which is typically used by the CDC to quickly notify clinicians and public health departments of emerging health threats. Some officials reportedly feared sounding “alarmist.” Others questioned whether the data truly warranted a full-scale warning. Ultimately, the HAN alert was shelved in favor of a more subdued website notice issued on May 28.
In the interim, internal talking points continued to describe the condition as rare and urged continued vaccination. The official FDA label for both the Pfizer and Moderna vaccines wasn’t updated to reflect the myocarditis risk until June 25.
The report, while critical, notes that many individuals who developed myocarditis, pericarditis, or myopericarditis after vaccination experienced a resolution of symptoms, a finding consistent with CDC data.
Senator Johnson, a frequent critic of the federal pandemic response, has argued that transparency was lacking during this period. “The full extent of the Biden administration’s failure to immediately warn the public about all COVID-19 vaccine adverse events must be completely exposed,” the report concludes.
Health officials involved in the decisions, including then-FDA commissioner Dr. Janet Woodcock and then-CDC director Dr. Rochelle Walensky, have not yet publicly responded to the findings in the interim report.
The release comes amid ongoing political scrutiny over pandemic-era decision-making and the future of public health communications in the wake of COVID-19. The Biden administration and health agencies have consistently maintained that the benefits of mRNA vaccines outweigh the risks, particularly during the height of the pandemic when COVID-19 posed a significant public health threat.
As investigations continue, Johnson’s subcommittee says it plans to further examine the internal communications and decision-making processes of the nation’s top health agencies.
A newly released analysis is raising serious questions about the safety profile of mifepristone, the drug responsible for over half of abortions in the United States. While abortion-rights advocates, corporate media outlets, and the U.S. Food and Drug Administration (FDA) maintain that the drug is “safe and effective,” a comprehensive study based on real-world insurance claims paints a far more concerning picture.
Described as the “largest known study of the abortion pill,” the report was conducted by Ethics and Public Policy Center President Ryan Anderson and Director of Data Analysis Jamie Bryan Hall. Using a massive dataset that included Medicaid, TRICARE, Medicare, Department of Veterans Affairs, and private insurance claims, the researchers analyzed 865,727 prescriptions of mifepristone distributed to 692,873 women between 2017 and 2023.
The findings are striking: approximately 10.9 percent of those chemical abortions—about 94,605 cases—involved potentially life-threatening “serious adverse events” within 45 days of taking the drug. These complications included emergency room visits, hemorrhage, sepsis, infection, and follow-up surgeries. This complication rate is at least 22 times higher than the <0.5 percent figure cited by the FDA on the Mifeprex label.
The researchers noted that some patients experienced complications in multiple categories, and that the 45-day window used for measurement was “conservative,” especially considering that the FDA has relied on studies using a timeframe of up to 72 days.
One chart from the study revealed that among women who sought post-abortion care within 45 days:
15.1% visited the emergency room,
8.5% required surgical treatment,
2.5% experienced hemorrhage,
1.9% suffered infections, and
0.9% were diagnosed with sepsis.
“These outcomes were drawn from actual claims data,” the researchers emphasized, “not modeled projections or self-reported surveys.” In Anderson’s words to The Federalist: “This study is the statistical equivalent of a category 5 hurricane hitting the prevailing narrative of the abortion industry. It reveals, based on real-world data, the shocking number of women who suffer serious medical consequences because of the abortion pill.”
The FDA originally approved mifepristone in 2000 based on 10 clinical trials involving only 30,966 patients—women who were described as “prescreened,” “generally healthy,” and treated in controlled environments. The authors of the new study argue that those trials are both outdated and unrepresentative of today’s broad and diverse patient base.
“The women in our dataset receive (or fail to receive) pre- and post-abortion healthcare of the real-world quality that prevails in the U.S. today, not the carefully controlled regimen of care that ordinarily prevails in a clinical trial,” the study says.
Despite repeated petitions from pro-life medical groups to revisit the approval of mifepristone, the FDA has consistently declined to take action. Critics argue the agency failed to meet its legal obligation to address the concerns. Meanwhile, regulatory oversight has continued to loosen. By 2016, the FDA under the Obama administration had altered the drug’s dosing, cut down the number of in-person doctor visits required, broadened who could prescribe it, and eliminated requirements to report non-fatal complications.
The Biden administration went further. In 2021, the FDA permanently allowed mifepristone to be delivered by mail, bypassing the need for a clinic visit. Pharmacies like Walgreens and CVS were later authorized to dispense the pill. As of 2023, a woman can obtain mifepristone with just one telehealth appointment with “any approved healthcare provider (not necessarily a physician)” and self-administer the drug at home. Alarmingly, prescribers are not required to report adverse events unless they learn the patient has died.
The study recommends that the FDA reinstate its original safety protocols. These would include requiring multiple in-person visits, physician-only prescribing, ultrasound confirmation of gestational age and the absence of ectopic pregnancy, and mandatory reporting of complications. The goal, according to the authors, is not only to reduce immediate harm but also to facilitate better long-term safety tracking.
“The FDA should further investigate the harm this drug causes to women and, based on objective safety criteria, reconsider its approval altogether. Women deserve better than the abortion pill,” the study concludes.
While legal efforts to challenge the pill’s availability have so far been unsuccessful, the issue remains live. In 2023, the Supreme Court declined to weigh in on the merits of mifepristone’s approval, ruling that the plaintiffs lacked standing. However, Justice Brett Kavanaugh’s opinion left open the possibility for the Court to consider a more suitable challenge in the future.
Buddy Broerman
July 16, 2023 at 12:29 am
This link (https://www.fda.gov/media/144413/download) in your article goes to an FDA page that says it doesn’t exist or is out of date? What did the page look like before they made it ‘out of date’?
Thanks,
Buddy
Pingback: 86% of Children Suffered an Adverse Reaction to the Pfizer Covid Vaccine in Clinical Trial - Dr. Rich Swier
James
July 21, 2023 at 9:52 pm
Clearly you live in a warped reality if you drew the above conclusions from the data provided. Instead of stupidly highlighting the 3% who didn’t get a 2nd vaccine, maybe focus on the overwhelming 97% of parents who were happy to give their child a 2nd dose. Clearly the ‘adverse’ effects you are trying to scaremonger people about were nothing for those 97% to worry about. It’s also funny how you made zero reference to all the ‘adverse’ reactions from a placebo. With such a high number of ‘fatigue’ side effects reported by kids from a basic placebo, the vaccine responses relating to fatigue (the highest side effect) is clearly unreliable. The only news story here is about parents trying to do the right thing and protect their kids from Covid. Just more fake news from a dimwit author trying to push a dangerous agenda.